⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2677860 | 0.81 | ALDH1A1 (0.48) | — | |
| SCHEMBL8951223 | 0.81 | ALDH1A1 (0.48) | — | |
| SCHEMBL103468 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL12367675 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL10791 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL967286 | 0.77 | — | — | |
| SCHEMBL8035901 | 0.75 | ALDH1A1 (0.48) | — | |
| SCHEMBL7932103 | 0.75 | ALDH1A1 (0.48) | — | |
| SCHEMBL965723 | 0.75 | ALDH1A1 (0.48) | — | |
| SCHEMBL12489264 | 0.75 | ALDH1A1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150216867-A1 | COMPOUNDS FOR USE IN GASTRIC COMPLICATION | NOVARTIS AG (CH) | 2015-08-06 | — | — | US | claimed |
| EP-2900237-A1 | COMPOUNDS FOR USE IN GASTRIC COMPLICATION | Novartis AG (CH) | 2015-08-05 | — | — | EP | claimed |
| EP-2694513-B1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2015-01-07 | — | — | EP | claimed |
| US-8748435-B2 | Pyrazolo pyrimidine derivatives | NOVARTIS AG (CH) | 2014-06-10 | — | — | US | claimed |
| EP-2694513-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | Novartis AG (CH) | 2014-02-12 | — | — | EP | claimed |
| US-20120252778-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2012-10-04 | — | — | US | claimed |
| WO-2012131633-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2012-10-04 | — | — | WO | claimed |
| US-20150216867-A1 | COMPOUNDS FOR USE IN GASTRIC COMPLICATION | NOVARTIS AG (CH) | 2015-08-06 | — | — | US | disclosed |
| EP-2900237-A1 | COMPOUNDS FOR USE IN GASTRIC COMPLICATION | Novartis AG (CH) | 2015-08-05 | — | — | EP | disclosed |
| EP-2694513-B1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2015-01-07 | — | — | EP | disclosed |
| US-8748435-B2 | Pyrazolo pyrimidine derivatives | NOVARTIS AG (CH) | 2014-06-10 | — | — | US | disclosed |
| EP-2694513-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | Novartis AG (CH) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012131633-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2012-10-04 | — | — | WO | disclosed |
| US-20120252778-A1 | PYRAZOLO PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2012-10-04 | — | — | US | disclosed |